Form 4: Slide Insurance CRO Executes Stock Option Exercise and Sale

Chief Risk Officer Matthew Larson exercised and sold 13,750 shares of Slide Insurance Holdings, Inc. common stock under a 10b5-1 plan.

Summary

• Matthew Larson, Chief Risk Officer of Slide Insurance Holdings, Inc., exercised stock options for 8,998 shares at $0.79 and 4,752 shares at $1.38.
• Following the exercise, the reporting person sold the total 13,750 shares at a weighted average price of $17.07 per share.
• The transactions were executed on June 10, 2026, pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2025.
• The reporting person retains 50,248 derivative securities in the form of stock options.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was conducted under a pre-established 10b5-1 plan, which is a routine mechanism for executive compensation realization.

Positives

• The transaction was pre-planned under a 10b5-1 trading plan, indicating a systematic approach to liquidity rather than reactive selling.
• The exercise of options demonstrates the realization of value from equity-based compensation.

Negatives

• The reporting person reduced their direct beneficial ownership of common stock to zero following the sale.

Risks

• Future vesting of remaining stock options is subject to continued employment and time-based conditions.

Future Outlook

The reporting person continues to hold 50,248 stock options, with remaining tranches scheduled to vest on July 14, 2026, and July 14, 2027.

Management Comments

• The reporting person will provide full information regarding the number of shares sold at each separate price upon request.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal financial planning and liquidity, and is generally viewed as neutral by the market when pre-arranged.

Comparison to Industry Standards

• The use of 10b5-1 plans is consistent with best practices for corporate governance and regulatory compliance among U.S. public companies.

Stakeholder Impact

• Minimal impact on shareholders as the sale was pre-planned and executed through a 10b5-1 trading plan.

Next Steps

• Remaining stock options will vest on July 14, 2026, and July 14, 2027.

Key Dates

Keywords

Slide Insurance, SLDE, Insider Trading, Form 4, Stock Options, Chief Risk Officer